Randomized Phase Ii Trial Of Durvalumab In Combination With Olaparib And Cediranib (Doc) Compared To Olaparib And Cediranib (Oc) Or Durvalumab And Cediranib (Dc) Or Standard Of Care Chemotherapy (Soc) In Platinum-Resistant Ovarian Cancer With Prior Bevacizumab (Nrg-Gy023)
Cediranib;Durvalumab;Olaparib;Cediranib;Durvalumab;Olaparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Randomized Phase Ii Trial Of Durvalumab In Combination With Olaparib And Cediranib (Doc) Compared To Olaparib And Cediranib (Oc) Or Durvalumab And Cediranib (Dc) Or Standard Of Care Chemotherapy (Soc) In Platinum-Resistant Ovarian Cancer With Prior Bevacizumab (Nrg-Gy023) ### Output: Cediranib;Durvalumab;Olaparib;Cediranib;Durvalumab;Olaparib